Home » Stocks » Champions Oncology

Champions Oncology, Inc. (CSBR)

Stock Price: $8.96 USD 0.12 (1.36%)
Updated Aug 7, 2020 4:00 PM EDT - Market closed

Stock Price Chart

Key Info

Market Cap 114.03M
Revenue (ttm) 32.12M
Net Income (ttm) -1.98M
Shares Out 12.05M
EPS (ttm) -0.17
PE Ratio n/a
Forward PE 84.75
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Aug 7, 2020
Last Price $8.96
Previous Close $8.84
Change ($) 0.12
Change (%) 1.36%
Day's Open 8.82
Day's Range 8.79 - 9.19
Day's Volume 14,391
52-Week Range 4.02 - 10.89

More Stats

Market Cap 114.03M
Enterprise Value 109.49M
Earnings Date (est) Sep 10, 2020
Ex-Dividend Date n/a
Shares Outstanding 12.05M
Float 5.35M
EPS (basic) -0.17
EPS (diluted) -0.17
FCF / Share 0.06
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield 0.60%
Payout Ratio n/a
Shares Short 162,941
Short Ratio 1.88
Short % of Float 2.08%
Beta 1.21
PE Ratio n/a
Forward PE 84.75
P/FCF Ratio 166.47
PS Ratio 3.55
PB Ratio 20.37
Revenue 32.12M
Operating Income -1.80M
Net Income -1.98M
Free Cash Flow 685,000
Net Cash 4.54M
Net Cash / Share 0.36
Gross Margin 47.45%
Operating Margin -5.61%
Profit Margin -6.10%
FCF Margin 2.13%
ROA -5.73%
ROE -52.28%
ROIC -31.90%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (3)

Buy 3
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: Buy

Price Target

$11.00*
(22.77% upside)
Low
10.0
Current: $8.96
High
12.0
Target: 11.00
*Average 12-month price target from 3 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year2020201920182017201620152014201320122011
Revenue32.1227.0720.2415.4111.188.8611.558.327.156.88
Revenue Growth18.68%33.72%31.34%37.82%26.16%-23.26%38.77%16.42%3.88%-
Gross Profit15.2412.809.695.712.501.235.293.002.253.37
Operating Income-1.800.27-1.35-6.81-10.32-13.24-6.26-6.22-9.07-5.24
Net Income-1.980.13-1.48-6.88-10.45-13.14-7.41-6.33-8.66-3.80
Shares Outstanding11.8411.3410.9910.688.705.995.574.343.902.81
Earnings Per Share-0.170.01-0.13-0.64-1.20-2.20-1.33-1.44-2.28-1.32
Operating Cash Flow2.911.86-1.23-2.84-6.41-9.63-3.43-4.30-5.23-0.05
Capital Expenditures-2.22-0.83-1.23-0.77-0.32-0.11-0.23-0.06-0.52-0.08
Free Cash Flow0.691.03-2.46-3.61-6.73-9.74-3.67-4.36-5.75-0.14
Cash & Equivalents8.343.241.013.452.749.526.069.754.9010.46
Total Debt3.800.020.04-------
Net Cash / Debt4.543.220.963.452.749.526.069.754.9010.46
Assets20.7511.278.088.015.7812.058.8711.656.9212.65
Liabilities15.439.038.087.615.543.995.673.984.044.47
Book Value5.322.24-0.400.248.063.20-9.21-5.280.02
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Champions Oncology, Inc.
Country United States
Employees 143
CEO Ronnie Morris

Stock Information

Ticker Symbol CSBR
Stock Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Unique Identifier NASDAQ: CSBR
IPO Date March 25, 1986

Description

Champions Oncology, Inc. develops and sells technology solutions and products to personalize the development and use of oncology drugs in the United States. Its Tumorgraft Technology Platform is an approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice. The company, through its Tumorgraft Technology Platform, provides Personalized Oncology Solutions (POS) that assist physicians in developing personalized treatment options for cancer patients through tumor specific data obtained from drug panels and related personalized oncology services. It also offers Translational Oncology Solutions that utilizes its technology platform to assist pharmaceutical and biotechnology companies with their drug development process. In addition, the company provides POS products, including TumorGraft implants and drug panels, which utilizes TumorGraft technology to test the response of a patient's tumor to multiple oncology drugs or drug combinations. It markets its products through internet, word of mouth, and sales force to patients and physicians. The company was formerly known as Champions Biotechnology, Inc. and changed its name to Champions Oncology, Inc. in April 2011. Champions Oncology, Inc. was incorporated in 1985 and is headquartered in Hackensack, New Jersey.